Methods of preparing stimuli-responsive multifunctional nanoparticles

Patent metadata

Field	Value
Publication number	US-10117837-B2
Application number	US-201715446387-A
Country	US
Kind code	B2
Filing date	Mar 1, 2017
Priority date	Mar 1, 2017
Publication date	Nov 6, 2018
Grant date	Nov 6, 2018

Abstract

Provided is a method of preparing a stimuli-responsive multifunctional nanoparticle, including in sequence the steps of: (a) conjugating covalently an active targeting moiety to a hydrophilic polymer to form a targeted polymer, (b) conjugating covalently a redox-responsive moiety to the hydrophilic polymer of the targeted polymer to form a targeted redox-responsive polymer, (c) conjugating covalently a pH-responsive moiety of a drug complex to the redox-responsive moiety of the targeted redox-responsive polymer to form a targeted stimuli-responsive polymer-drug conjugate, wherein the drug complex includes a hydrophobic drug covalently linked to the pH-responsive moiety, and (d) adding the targeted stimuli-responsive polymer-drug conjugate and optionally an imaging agent into an aqueous liquid to allow self-assembly into a stimuli-responsive multifunctional nanoparticle, wherein the hydrophobic drug of the stimuli-responsive multifunctional nanoparticle forms a hydrophobic core, and the imaging agent is incorporated within the hydrophobic core.

First claim

What is claimed is:

1. A method of preparing a stimuli-responsive multifunctional nanoparticle, comprising in sequence the steps of:
(a) conjugating covalently an active targeting moiety to a hydrophilic polymer to form a targeted polymer at acidic pH, wherein the active targeting moiety is a peptide specific for cancer cells and the hydrophilic polymer is hyaluronic acid;
(b) conjugating covalently a redox-responsive moiety to the hydrophilic polymer of the targeted polymer to form a targeted redox-responsive polymer, wherein the redox-responsive moiety comprises a disulfide bond;
(c) conjugating covalently a pH-responsive moiety of a drug complex to the redox-responsive moiety of the targeted redox-responsive polymer to form a targeted stimuli-responsive polymer-drug conjugate, wherein pH-responsive moiety comprises an acid-labile linkage that is hydrolyzed between pH 5 and pH 7, and the drug complex comprises a hydrophobic drug covalently linked to the pH-responsive moiety; and
(d) adding the targeted stimuli-responsive polymer-drug conjugate into an aqueous liquid to allow self-assembly into a stimuli-responsive multifunctional nanoparticle, wherein the hydrophobic drug of the stimuli-responsive multifunctional nanoparticle forms a hydrophobic core.

2. The method of claim 1 , further comprising the step of adding an imaging agent into the aqueous liquid in step (d) to allow the imaging agent to be incorporated within the hydrophobic core of the stimuli-responsive multifunctional nanoparticle.

3. The method of claim 2 , wherein the imaging agent is a near-infrared fluorescent dye.

4. The method of claim 1 , wherein in step (a) the hyaluronic acid has a molecular weight of below 20 kDa.

5. The method of claim 1 , wherein in step (a) the peptide has 5-20 amino acid residues.

6. The method of claim 1 , wherein the peptide is a luteinizing hormone-releasing hormone peptide or an analog thereof.

7. The method of claim 1 , wherein redox-responsive moiety is cystamine or an analog thereof.

8. The method of claim 1 , wherein the pH-responsive moiety is a cis-aconityl group.

9. The method of claim 1 , wherein in step (c) the hydrophobic drug is an anticancer drug.

10. The method of claim 2 , wherein in step (d) the targeted stimuli-responsive polymer-drug conjugate and the imaging agent are in a weight ratio of about 10:1 to 15:1.

11. The method of claim 1 , wherein the stimuli-responsive multifunctional nanoparticle is at a size of about 150-300 nm.

Assignees

• Univ Nat Tsing Hua

Inventors

• Lin Chun-Jui
• Wang Tzu-Wei

Classifications

• A61K38/09 Primary

  Luteinising hormone-releasing hormone [LHRH] {, i.e. Gonadotropin-releasing hormone [GnRH]}; Related peptides · CPC title

• A61K49/0091

  Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer · CPC title

• A61K9/5036 Primary

  Polysaccharides, e.g. gums, alginate; Cyclodextrin · CPC title

• A61K47/4823

  Human Necessities · mapped topic

• A61K47/61

  the organic macromolecular compound being a polysaccharide or a derivative thereof · CPC title